Trial for advanced breast cancer withdrawn before starting
NCT ID NCT06585969
Summary
This trial was planned to compare a newer drug (trastuzumab deruxtecan) against standard treatments for a specific type of advanced breast cancer that has spread. It aimed to see which approach was better at controlling the disease and delaying its progression. However, the trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.